Monica Campo1, Krisann K Oursler, Laurence Huang, Matthew Bidwell Goetz, David Rimland, Guy Soo Hoo, Sheldon T Brown, Maria C Rodriguez-Barradas, David Au, Kathleen M Akgün, Shahida Shahrir, Kristina Crothers. 1. *Department of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA; †The Baltimore Veterans Affairs Medical Center, Geriatric Research, Education, and Clinical Center, Baltimore, MD; ‡University of Maryland School of Medicine, Baltimore, MD; §Division of Pulmonary and Critical Care Medicine and HIV/AIDS Division, Department of Medicine, University of California, San Francisco, CA; ‖Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA; ¶Department of Medicine, Infectious Diseases Section, University of California-Los Angeles, David Geffen School of Medicine, Los Angeles, CA; #Division of Infectious Diseases, Atlanta Veterans Affairs Medical Center; **Department of Medicine, Emory University School of Medicine, Atlanta, GA; ††Pulmonary and Critical Care Section, West Los Angeles Healthcare Center, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA; ‡‡James J. Peters Veterans Affairs Medical Center; §§Department of Medicine and Infectious Diseases, Icahn School of Medicine at Mount Sinai, Bronx, NY; ‖‖Infectious Diseases Section, Michael E. DeBakey VAMC, Houston, Texas; ¶¶Department of Medicine, Baylor College of Medicine, Houston, Texas; and ##Department of Internal Medicine, Veterans Affairs Connecticut Healthcare System, West Haven, CT; ***Yale School of Medicine, New Haven, CT.
Abstract
OBJECTIVE: Chronic lung disease has been associated with greater impairment in self-reported physical function in HIV-infected patients. We sought to study this association using objective measures of physical function and pulmonary function. DESIGN: Baseline data from the Examinations of HIV Associated Lung Emphysema study, a multicenter observational cohort of HIV-infected and uninfected veterans. METHODS: We assessed the association between clinical, laboratory, and pulmonary function measures with 6-minute walk test (6-MWT). Multivariable linear regression models were generated to identify factors associated with 6-MWT performance. RESULTS: Three hundred forty participants completed 6-MWT (mean age 55 years), with 68% blacks, 94% men, and 62% current smokers. Overall, 180 (53%) were HIV-infected and 63 (19%) had spirometry-defined chronic obstructive pulmonary disease. In a multivariable model, age, current smoking, and obesity (body mass index > 30) were independently associated with lower 6-MWT performance, but HIV infection was not; there was a significant interaction between HIV and chronic cough, such that distance walked among HIV-infected participants with chronic cough was 51.76 m less (P = 0.04) compared with those without cough or HIV. Among HIV-infected participants, the forced expiratory volume in 1 second (FEV1, percent predicted), to a greater extent than total lung capacity or diffusing capacity, attenuated the association with chronic cough; decreased FEV1 was independently associated with lower 6-MWT performance in those with HIV. CONCLUSIONS: Older age, current smoking, and airflow limitation were important determinants of 6-MWT performance in the HIV-infected participants. These findings suggest that potential interventions to improve physical function may include early management of respiratory symptoms and airflow limitation.
OBJECTIVE:Chronic lung disease has been associated with greater impairment in self-reported physical function in HIV-infectedpatients. We sought to study this association using objective measures of physical function and pulmonary function. DESIGN: Baseline data from the Examinations of HIV Associated Lung Emphysema study, a multicenter observational cohort of HIV-infected and uninfected veterans. METHODS: We assessed the association between clinical, laboratory, and pulmonary function measures with 6-minute walk test (6-MWT). Multivariable linear regression models were generated to identify factors associated with 6-MWT performance. RESULTS: Three hundred forty participants completed 6-MWT (mean age 55 years), with 68% blacks, 94% men, and 62% current smokers. Overall, 180 (53%) were HIV-infected and 63 (19%) had spirometry-defined chronic obstructive pulmonary disease. In a multivariable model, age, current smoking, and obesity (body mass index > 30) were independently associated with lower 6-MWT performance, but HIV infection was not; there was a significant interaction between HIV and chronic cough, such that distance walked among HIV-infectedparticipants with chronic cough was 51.76 m less (P = 0.04) compared with those without cough or HIV. Among HIV-infectedparticipants, the forced expiratory volume in 1 second (FEV1, percent predicted), to a greater extent than total lung capacity or diffusing capacity, attenuated the association with chronic cough; decreased FEV1 was independently associated with lower 6-MWT performance in those with HIV. CONCLUSIONS: Older age, current smoking, and airflow limitation were important determinants of 6-MWT performance in the HIV-infectedparticipants. These findings suggest that potential interventions to improve physical function may include early management of respiratory symptoms and airflow limitation.
Authors: Philip T Diaz; Mark D Wewers; Eric Pacht; Janice Drake; Haikady N Nagaraja; Thomas L Clanton Journal: Chest Date: 2003-06 Impact factor: 9.410
Authors: Melanie Rusch; Stephanie Nixon; Arn Schilder; Paula Braitstein; Keith Chan; Robert S Hogg Journal: Health Qual Life Outcomes Date: 2004-09-06 Impact factor: 3.186
Authors: Rachel M Presti; Sonia C Flores; Brent E Palmer; Jeffrey J Atkinson; Catherine R Lesko; Bryan Lau; Andrew P Fontenot; Jesse Roman; John F McDyer; Homer L Twigg Journal: Chest Date: 2017-04-17 Impact factor: 9.410
Authors: Matthew Triplette; Amy Justice; Engi F Attia; Janet Tate; Sheldon T Brown; Matthew Bidwell Goetz; Joon W Kim; Maria C Rodriguez-Barradas; Guy W Soo Hoo; Cherry Wongtrakool; Kathleen Akgün; Kristina Crothers Journal: AIDS Date: 2018-02-20 Impact factor: 4.177
Authors: Jessica L Montoya; Catherine M Jankowski; Kelly K O'Brien; Allison R Webel; Krisann K Oursler; Brook L Henry; David J Moore; Kristine M Erlandson Journal: AIDS Date: 2019-05-01 Impact factor: 4.177
Authors: M Bradley Drummond; Laurence Huang; Philip T Diaz; Gregory D Kirk; Eric C Kleerup; Alison Morris; William Rom; Michael D Weiden; Enxu Zhao; Bruce Thompson; Kristina Crothers Journal: AIDS Date: 2015-08-24 Impact factor: 4.177
Authors: Kristine M Erlandson; Jennifer A Schrack; Catherine M Jankowski; Todd T Brown; Thomas B Campbell Journal: Curr HIV/AIDS Rep Date: 2014-09 Impact factor: 5.071